Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

PURPOSE: The Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial established perioperative epirubicin, cisplatin, and fluorouracil chemotherapy as a standard of care for patients with resectable esophagogastric cancer. However, identification of patients at risk for relap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Smyth, Elizabeth C., Fassan, Matteo, Cunningham, David, Allum, William H., Okines, Alicia F.C., Lampis, Andrea, Hahne, Jens C., Rugge, Massimo, Peckitt, Clare, Nankivell, Matthew, Langley, Ruth, Ghidini, Michele, Braconi, Chiara, Wotherspoon, Andrew, Grabsch, Heike I., Valeri, Nicola
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2016
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5019747/
https://ncbi.nlm.nih.gov/pubmed/27298411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.65.7692
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars